// App-Quantinova.ai

: Baseline plasma total tau predicts longitudinal cognitive and functional decline in aging adults

Researchers

Presenter

  • Corey J Bolton

Principal Investigators

  • Omair A. Khan

  • Dandan Liu

  • Elizabeth E. Moore

  • Kimberly R. Pechman

  • Kaj Blennow

  • Henrik Zetterberg

  • Timothy J. Hohman

  • Katherine A. Gifford

  • Angela L. Jefferson

Medical Centers

  • Vanderbilt Memory & Alzheimer’s Center, Department of Neurology, Vanderbilt University Medical Center

  • Vanderbilt University Medical Center, Nashville, TN

  • Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center

  • Vanderbilt Genetics Institute, Vanderbilt University Medical Center

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • UK Dementia Research Institute

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

  • Dementia

  • Stroke

Biomarkers

  • Apolipoprotein E

  • Tau protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved